Haemonetics | HAE - Interest Expense On Debt


Haemonetics reported $7.4M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 96M 6M Jun/2026
Cerus USD 2.33M 96K Jun/2024
Cooper Companies USD 20.9M 1.5M Mar/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 79M 6M Mar/2026
Globus Medical USD 5.44B 5.44B Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
ICU Medical USD 20.64M 21.39M Dec/2025
Intuitive Surgical USD 20.88B 765.6M Jun/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Plus Therapeutics USD 62K 25K Dec/2023
Quidel USD 5.63B 5.58B Mar/2026
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 800K 799K Sep/2025
Steris USD 14.9M 0 Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Teleflex USD 25.72M 2.43M Mar/2026
Terumo JPY 1.53B 1.06B Mar/2026
Thermo Fisher Scientific USD 354M 11M Mar/2026
US Physical Therapy USD 2.79M 441K Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026